Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.
作者信息
Barakat M T, Scott J, Hughes J M, Walport M, Calam J, Friedland J S, Ind P W, McKenna C
机构信息
Hammersmith Hospital, London.
出版信息
BMJ. 1996 Dec 14;313(7071):1543-5. doi: 10.1136/bmj.313.7071.1543.
Abstract
摘要
相似文献
1
Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.大查房——哈默史密斯医院。肺结核持续发热
BMJ. 1996 Dec 14;313(7071):1543-5. doi: 10.1136/bmj.313.7071.1543.
2
[Fever and thin-walled cavitary lung lesions].[发热与薄壁肺空洞病变]
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):363-4. doi: 10.1016/j.eimc.2008.07.010. Epub 2009 May 6.
3
Concurrent mucosal leishmaniasis and pulmonary tuberculosis.黏膜利什曼病与肺结核并存。
Clin Infect Dis. 1996 Oct;23(4):836-7. doi: 10.1093/clinids/23.4.836.
4
New TB drug approved.新型结核病药物获批。
AIDS Patient Care. 1995 Feb;9(1):42.
5
Good news and not such good news.
Int J Tuberc Lung Dis. 1999 Feb;3(2):87.
6
[Myrin P in the combined treatment of tuberculosis].
Antibiot Khimioter. 2002;47(6):22-7.
7
Chemotherapy of tuberculosis for patients with renal impairment.
Nephron. 1993;64(2):169-81. doi: 10.1159/000187310.
8
[Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].[第二阶段使用和不使用吡嗪酰胺的结核病短期治疗（TA-80）]
Rev Med Chil. 1983 Jul;111(7):750-4.
9
Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis.肺结核患者的肠道屏障功能和利福平、异烟肼及吡嗪酰胺的血清浓度。
Braz J Infect Dis. 2009 Jun;13(3):210-7. doi: 10.1590/s1413-86702009000300011.
10
[Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].异烟肼与吡嗪酰胺以及异烟肼与利福平治疗肺结核的对比研究
Wien Med Wochenschr. 1982 Nov 30;132(22):559-61.
引用本文的文献
1
Persistent Fever in Tuberculosis: Clinical Experience and Literature Review.肺结核中的持续发热：临床经验与文献综述
Cureus. 2024 Sep 14;16(9):e69391. doi: 10.7759/cureus.69391. eCollection 2024 Sep.
2
Therapeutic drug monitoring in tuberculosis.结核病治疗药物监测。
Eur J Clin Pharmacol. 2024 Nov;80(11):1659-1684. doi: 10.1007/s00228-024-03749-8. Epub 2024 Sep 6.
3
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.晚期人类免疫缺陷病毒病患者中利福平及其他抗结核药物的生物利用度降低。
Antimicrob Agents Chemother. 2004 Nov;48(11):4473-5. doi: 10.1128/AAC.48.11.4473-4475.2004.
本文引用的文献
1
Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months.
Am Rev Respir Dis. 1993 Apr;147(4):1062-3. doi: 10.1164/ajrccm/147.4.1062.
2
Pharmacology of the antimycobacterial drugs.抗分枝杆菌药物的药理学
Med Clin North Am. 1993 Nov;77(6):1253-62. doi: 10.1016/s0025-7125(16)30191-2.
3
Corticosteroids and tuberculosis.
Respir Med. 1994 Sep;88(8):561-5. doi: 10.1016/s0954-6111(05)80002-2.
4
Chemotactic cytokines and tuberculosis.趋化性细胞因子与结核病
Biochem Soc Trans. 1994 May;22(2):310-2. doi: 10.1042/bst0220310.
5
Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature.泼尼松作为肺结核治疗的辅助疗法。12例报告及文献综述。
Chest. 1995 Jun;107(6):1621-30. doi: 10.1378/chest.107.6.1621.
6
Obstructive lung disease. Percutaneous needle biopsy.
Chest. 1995 May;107(5):1476-7. doi: 10.1378/chest.107.5.1476.
7
Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection.致命性结核分枝杆菌感染中离体促炎细胞因子分泌的抑制作用
Clin Exp Immunol. 1995 May;100(2):233-8. doi: 10.1111/j.1365-2249.1995.tb03659.x.
8
Rifampicin kinetics in undernutrition.营养不良时利福平的动力学
Br J Clin Pharmacol. 1984 Apr;17(4):481-4. doi: 10.1111/j.1365-2125.1984.tb02377.x.
9
The Australian rifampicin trial.澳大利亚利福平试验。
Med J Aust. 1971 Jul 10;2(2):85-94.
10
Effect of meals on rifampicin absorption.进餐对利福平吸收的影响。
Lancet. 1974 Jul 27;2(7874):197-8. doi: 10.1016/s0140-6736(74)91487-1.
Zotero 插件